Detalhe da pesquisa
1.
A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial.
Oncologist
; 24(12): e1409-e1416, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420467
2.
Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2.
Cancer
; 124(9): 1982-1991, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29451696
3.
A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial.
Oncologist
; 22(12): 1427-e129, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935773
4.
Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer.
Breast Cancer Res Treat
; 152(3): 557-67, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26155975
5.
Sorafenib and everolimus in advanced clear cell renal carcinoma: a phase I/II trial of the SCRI Oncology Research Consortium.
Cancer Invest
; 31(5): 323-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23614653
6.
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
Lung Cancer
; 117: 38-43, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496254
7.
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI).
Lung Cancer
; 113: 79-84, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29110854
8.
Phase I. Trial of irinotecan and temozolomide in patients with solid tumors.
Oncology (Williston Park)
; 17(5 Suppl 5): 41-5, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12800606
9.
High-dose bevacizumab in the treatment of patients with advanced clear cell renal carcinoma: a phase II trial of the Sarah Cannon Oncology Research Consortium.
Clin Genitourin Cancer
; 11(3): 283-289.e1, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23684421
10.
Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer.
Clin Colorectal Cancer
; 11(1): 45-52, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21840771
11.
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.
J Thorac Oncol
; 7(1): 196-202, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21900836
12.
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
Lung Cancer
; 78(1): 70-5, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22947511
13.
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortium.
Cancer J
; 17(5): 267-72, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21952273
14.
A phase II study of higher dose weekly topotecan in relapsed small-cell lung cancer.
Clin Lung Cancer
; 12(3): 187-91, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21663862
15.
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.
J Clin Oncol
; 29(18): 2582-9, 2011 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576636
16.
Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.
J Clin Oncol
; 25(13): 1747-52, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17470864
17.
Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network.
Cancer
; 110(9): 2027-34, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17823908